Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Through direct negotiations with the medications' manufacturers, Evernorth has ensured that patients' monthly cost will not exceed $200
Januvia is not expected to harm an unborn baby
Quick Navigation Report Overview Key Takeaways Product Type Analysis Route of Administration Analysis Application Analysis Distribution Channel Analysis Key Market Segments Drivers Restraints Opportunities Impact of Macroeconomic / Geopolitical Factors Latest Trends Regional Analysis Key Players Analysis Recent Developments Report Scope Report Overview Global GLP-1 Receptor Agonist Market size is expected to be worth around US$ 268.4 billion by 2034 from US$ 53.5 billion in 2024, growing at a CAGR of 17.5% during the forecast period 2025 to 2034
Developed with cutting-edge technology, Compounded Tirzepatide mimics natural hormones to aid in weight loss, making it a unique ally in your health journey
US$ 29.23
US$ 28.13
US$ 26.29
US$ 24.02
